Activation of metabotropic glutamate 2/3 receptors as a new approach for the treatment of schizophrenia

被引：0

作者：

Monn, James A. ^{[1
]}

机构：

[1] Eli Lilly & Co, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2012年 / 244卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

205-MEDI

引用

页数：1

共 50 条

[1] Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia
Conn, P. Jeffrey
Lindsley, Craig W.
Jones, Carrie K.
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2009, 30 (01) : 25 - 31
[2] New directions in the drug treatment of schizophrenia: metabotropic glutamate receptors
Schoepp, D.
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S179 - S179
[3] Targeting of Metabotropic Glutamate Receptors for the Treatment of Schizophrenia
Chaki, Shigeyuki
Hikichi, Hirohiko
[J]. CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (02) : 94 - 102
[4] Allosteric potentiators of metabotropic glutamate receptors as a novel approach for treatment of schizophrenia
Conn, P. J.
[J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S31 - S31
[5] Positive allosteric modulators of metabotropic glutamate 2 receptors in schizophrenia treatment
Ellaithy, Amr
Younkin, Jason
Gonzalez-Maeso, Javier
Logothetis, Diomedes E.
[J]. TRENDS IN NEUROSCIENCES, 2015, 38 (08) : 506 - 516
[6] Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of Schizophrenia
Dogra, Shalini
Conn, P. Jeffrey
[J]. MOLECULAR PHARMACOLOGY, 2022, 101 (05) : 275 - 285
[7] Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia
Bita Moghaddam
[J]. Psychopharmacology, 2004, 174 : 39 - 44
[8] Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia
Moghaddam, B
[J]. PSYCHOPHARMACOLOGY, 2004, 174 (01) : 39 - 44
[9] Metabotropic Glutamate Receptors: Potential Drug Targets for the Treatment of Schizophrenia
Chavez-Noriega, Laura E.
Schaffhauser, Herve
Campbell, Una C.
[J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (03) : 261 - 281
[10] Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition
Marek, Gerard J.
[J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 639 (1-3) : 81 - 90

← 1 2 3 4 5 →